磁共振弹性成像测得的肝脏硬度不受肝脂肪变性影响
该回顾性研究纳入256例在1年内接受肝活检和MRI/MRE检查的患者,评估活检证实的肝脂肪变性、MRI-PDFF与MRE测得的肝脏硬度之间的关系。结果显示PDFF区分脂肪变性分级的诊断准确率高于0.82,在调整纤维化分期和年龄后,肝硬度与PDFF之间无统计学显著关系(估计值=-0.02,p=0.065)。结论认为在NAFLD患者中,肝脂肪变性严重程度对MRE肝硬度测量无显著影响。
要点
- MRE肝硬度测量不受肝脂肪变性严重程度显著影响,阅片时无需因脂肪变而过度解读硬度值。
- MRI-PDFF可高准确度定量评估肝脂肪变性,区分S0-3级的诊断准确率高于0.82。
- 调整纤维化分期和年龄后,肝硬度与PDFF无统计学显著关系(p=0.065)。
诊断标准与关键数值
- PDFF区分肝脂肪变性分级(S0-3)的诊断准确率高于0.82。
- 在诊断为脂肪变性(PDFF≥5%)的患者中,调整纤维化分期和年龄后,LSM与PDFF无统计学显著关系(估计值=-0.02,p=0.065)。
- 按纤维化分期分组后,S1、S2、S3脂肪变性患者之间以及所有脂肪变性分级之间的LSM均无显著差异。
临床应用与阅片要点
- 日常阅片中,MRE肝硬度值可主要用于评估纤维化,肝脂肪变性程度不构成显著混杂。
- 可结合MRI-PDFF定量评估脂肪变性,其区分S0-3级的准确率高于0.82。
局限性
- 回顾性研究设计。
- 肝活检与MRI/MRE检查间隔在1年以内。
- 单中心研究。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
OBJECTIVES: To evaluate the relationship between biopsy-assessed hepatic steatosis, magnetic resonance imaging (MRI)-assessed proton density fat fraction (PDFF), and magnetic resonance elastography (MRE)-assessed liver stiffness measurement (LSM), in patients with or at risk for nonalcoholic fatty liver disease (NAFLD).
METHODS: A retrospective study was performed, encompassing 256 patients who had a liver biopsy and MRI/MRE examination performed within 1 year. Clinical and laboratory data were retrieved from the electronic medical record. Hepatic steatosis and fibrosis were assessed by histopathological grading/staging. First, we analyzed the diagnostic performance of PDFF for distinguishing hepatic steatosis with the receiver operating characteristic analyses. Second, variables influencing LSM were screened with univariant analyses, then identified with multivariable linear regression. Finally, the potential relationship between PDFF and LSM was assessed with linear regression after adjustment for other influencing factors, in patients with diagnosed steatosis (PDFF ≥ 5%).
RESULTS: The diagnostic accuracy of PDFF in distinguishing steatosis grades (S0-3) was above 0.82. No significant difference in LSM was found between patients with S1, S2, and S3 steatosis and between all steatosis grades after patients were grouped according to fibrosis stage. No statistically significant relationship was found between the LSM and PDFF (estimate = - 0.02, p = 0.065) after adjustment for fibrosis stage and age in patients with diagnosed steatosis (PDFF ≥ 5%).
CONCLUSIONS: In patients with NAFLD, the severity of hepatic steatosis has no significant influence on the liver stiffness measurement with magnetic resonance elastography.
KEY POINTS: • The MRI-based proton density fat fraction provides a quantitative assessment of hepatic steatosis with high accuracy. • No significant effect of hepatic steatosis on MRE-based liver stiffness measurement was found in patients with S1, S2, and S3 steatosis and between all steatosis grades after patients were grouped according to fibrosis stage. • After adjusting for fibrosis stage and age, there was no statistically significant relationship between liver stiffness and proton density fat fraction in patients with hepatic steatosis (p = 0.065).
引用
- Chen J, Allen AM, Therneau TM, et al. Liver stiffness measurement by magnetic resonance elastography is not affected by hepatic steatosis. Eur Radiol. 2021. PMID: 34432123. doi:10.1007/s00330-021-08225-w
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。